News

Fontainebleau/Geneva/Singapore - Switzerland is once again top of the global rankings for developing, attracting and retaining talent, followed by Singapore and the U.S. These are the findings of the Global Talent Competitiveness Index 2023, which is produced by the global INSEAD Business School.

Lugano/Osaka - The biotechnology companies Healiva and C4U are striving to help so-called “butterfly children” as part of their strategic partnership. Together, the partners will combat the devastating skin disease epidermolysis bullosa with gene therapy solutions based on DNA modification.

In this interview, Marco Casanova, the director of the ESG Center of Excellence, discusses the reasons behind choosing Lugano as the location for the initiative, their collaboration with local blockchain associations, and upcoming events focused on ESG and blockchain integration.

Schlieren/Seon/Vevey - A trio of Swiss companies, namely HeiQ, Mammut and Nespresso, have joined forces to create a particularly lightweight insulating jacket known as the Extraordinary Jacket. The insulation developed by Mammut contains HeiQ technology using aluminum obtained from recycled Nespresso capsules.

Chiasso/Bern - SBB, Swiss Federal Railways, has put its renovated cargo workshop in Chiasso into operation. The project took 18 months to complete, with the Swiss national railway company investing more than 12 million Swiss francs in the renovation. By expanding and modernizing the facility, SBB will be able to accelerate maintenance and servicing of locomotives and freight wagons.

Greater Zurich Area Ltd. appoints new class of Ambassadors for the global promotion of Greater Zurich Area as a technology and business location.

Zurich/Cambridge - The Boston Dynamics AI Institute of the Hyundai Motor Company will establish a presence in Greater Zurich at the start of 2024. The team in place here is set to focus on core areas of the institute such as Artificial Intelligence (AI), hardware design, machine learning, mobile manipulation and robot ethics.

Zurich - SIX Swiss Exchange, Swiss National Bank and six commercial banks are working together to trial tokenized central bank money for financial institutions. The pilot project is set to run from December 2023 through to June 2024.

Schlieren/Pfäffikon - Memo Therapeutics has raised 25 million Swiss francs to complete the Phase II clinical trials of AntiBKV for kidney infections in transplantation. The Series C financing was led by Pureos Bioventures.